Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
73,581,273
-
Total 13F shares
-
48,846,831
-
Share change
-
-464,169
-
Total reported value
-
$519,237,991
-
Put/Call ratio
-
26%
-
Price per share
-
$10.63
-
Number of holders
-
164
-
Value change
-
-$2,727,981
-
Number of buys
-
89
-
Number of sells
-
70
Institutional Holders of Health Catalyst, Inc. - Common Stock, $0.01 par value (HCAT) as of Q4 2022
As of 31 Dec 2022,
Health Catalyst, Inc. - Common Stock, $0.01 par value (HCAT) was held by
164 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
48,846,831 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, MILLENNIUM MANAGEMENT LLC, Balyasny Asset Management LLC, Point72 Asset Management, L.P., Daventry Group, LP, GOLDMAN SACHS GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, and STATE STREET CORP.
This page lists
164
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.